Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
114,7 INR | +0,07% | +13,06% | +14,13% |
Vakgebied
Aantal werknemers: 869
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Formulations and Active Pharmaceutical Ingredients
99,1
%
| 2 797 | 99,5 % | 3 016 | 99,1 % | +7,83% |
Other
0,8
%
| 15 | 0,5 % | 25 | 0,8 % | +65,54% |
Services
0,0
%
| 0 | 0,0 % | 1 | 0,0 % | +5.385,71% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
India
100,0
%
| 2 812 | 100,0 % | 3 042 | 100,0 % | +8,18% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 01-08-94 | |
Director of Finance/CFO | - | 02-06-23 | |
Abdul Basith
CMP | Compliance Officer | - | 17-07-23 |
M. P. George
COO | Chief Operating Officer | - | 10-05-12 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 01-08-94 | |
C. V. Srinivas
BRD | Director/Board Member | 58 | 29-06-19 |
Director/Board Member | - | 28-09-19 | |
H. S. Venkatesh
BRD | Director/Board Member | - | 23-05-20 |
Nicola Neeladri
BRD | Director/Board Member | - | 23-05-20 |
Jatish Sheth
BRD | Director/Board Member | - | 28-12-20 |
Director/Board Member | 63 | 30-05-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 15 804 372 | 5 327 032 ( 33,71 %) | 0 | 33,71 % |
Bedrijfsgegevens
Bal Pharma Ltd.
Lakshmi Narayan Complex 10/1, Palace Road
560052, Bangalore
+91 80 4137 9500
http://www.balpharma.comSector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,13% | 21,55 mln. | |
+40,73% | 739 mld. | |
+31,77% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+14,79% | 240 mld. | |
+9,52% | 210 mld. | |
-4,95% | 206 mld. | |
+6,17% | 164 mld. |
- Beurs
- Aandelen
- Koers BALPHARMA
- Onderneming Bal Pharma Limited